Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics
Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]
£3 Million More to Reduce Brain Injuries at Birth
NHS maternity staff will benefit from a further £3 million to improve the safety of […]
Biomunex Pharmaceuticals’ Breakthrough Immunotherapy Project Receives Grants Close to €3 Million
Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapy through the discovery and development of bi- and multi-specific […]
Closed Loop Medicine Closes £13 Million Financing
Closed Loop Medicine (the “Company”), the global leader in the development of single prescription drug […]
Draper Esprit Leads $17.5 Million Series A in Hypertension Health-tech Firm Aktiia
Draper Esprit, a leading venture capital firm investing in and developing high growth technology businesses, […]
Vensica Therapeutics Closes $16 Million Investment Round
Vensica Therapeutics (“Vensica”), a clinical stage biopharmaceutical company, announced that it has closed an investment round […]
Sphere Fluidics Closes a $40 Million Funding Round Led by Sofinnova Partners and Redmile Group
Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned […]
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures, and Tiger Global
Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series […]
Anomaly Raises $17 Million to Scale Precision Payments Platform Across Healthcare Industry
Anomaly, a precision payments platform using artificial intelligence (AI) to improve payment accuracy in the […]
Exciva Raises €9 Million in Series A Round Led by Andera Partners
Exciva GmbH, a clinical biotech company developing a novel therapeutic compound for treating agitation/aggression in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more